Logiscreen

Summit Therapeutics Inc

$14.77
Market Cap 11.45B
ROE -291.2%
Gross Margin 0.0%
Debt/Equity 0.0
Current Ratio 7.4
Revenue QoQ 0.0%
EPS QoQ 1.0%
F-Score 2

About

No Description Available

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-9.54
vs median 31.50
P/B
21.08
vs median 2.17
ROE
-2.91
vs median 0.09

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics